G01N 2333/90248
With nadh or nadph as one of the donors, and incorporation of
Official title: with NADH or NADPH as one of the donors, and incorporation of one atom of oxygen 1.14.13
G01N2333/90248 (With nadh or nadph as one of the donors, and incorporation of) appears on 29 US grants and 57 published applications in this corpus.
Search patents in G01N- Granted patents
- 29
- Published applications
- 57
- Assignees
- 40
- Inventors
- 94
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 1 |
| 2011 | 0 | 6 |
| 2012 | 1 | 4 |
| 2013 | 2 | 4 |
| 2014 | 3 | 5 |
| 2015 | 3 | 7 |
| 2016 | 2 | 4 |
| 2017 | 4 | 4 |
| 2018 | 2 | 3 |
| 2019 | 2 | 3 |
| 2020 | 2 | 2 |
| 2021 | 1 | 4 |
| 2022 | 1 | 0 |
| 2023 | 3 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method and agents for detecting luciferase activity18 Nov 2025US 12,473,582 B2Light Bio, Inc.
- Hair-growth promoting composition and usage thereof19 Mar 2024US 11,931,325 B2Eaderm Co., Ltd.
- Method and agents for detecting luciferase activity31 Oct 2023US 11,802,302 B2Light Bio, Inc.
- Method for determining the distinctive nutritional requirements of a patient28 Mar 2023US 11,614,442 B2Societe des Produits Nestle S. A.
- In-vivo probe for real time longitudinal monitoring of inducible nitric-oxide synthase in living cells and animals28 Feb 2023US 11,591,476 B2
- Method of predicting success of a cancer therapy13 Aug 2026US 2026/0235610 A1Immusmol SAS
- High density 3d hepatocyte spheroid platform for drug adme studies29 May 2025US 2025/0172543 A1Discovery Life Sciences, LLC
- Method and agents for detecting luciferase activity18 Jan 2024US 2024/0018566 A1Light Bio, Inc.
- Biomarkers and classifier of psoriasis and methods of treatment13 Jul 2023US 2023/0220479 A1Icahn School of Medicine at Mount Sinai
- Methods for assessing efficacy of a drug in vivo by monitoring adme proteins in extracellular vesicles2 Dec 2021US 2021/0372996 A1
Most cited
By later US patents
- Luminescence-based methods and probes for measuring cytochrome P450 activity22US 7,692,022 B2Promega Corporation · 2010
- Methods useful for vitamin D deficiency and related disorders21US 8,962,239 B2Opko IP Holdings II, Inc. · 2015
- Methods useful for vitamin D deficiency and related disorders18US 9,500,661 B2Opko Ireland Global Holdings, Ltd. · 2016
- Method for determining the distinctive nutritional requirements of a patient14US 10,768,169 B2Societe des Produits Nestle S. A. · 2020
- Luminescence-based methods and probes for measuring cytochrome P450 activity14US 8,106,052 B2Promega Corporation · 2012